share_log

Argenx Says US FDA Lenghtens Review for Investigational Treatment of Generalized Myasthenia Gravis

Argenx Says US FDA Lenghtens Review for Investigational Treatment of Generalized Myasthenia Gravis

Argenx 表示,美国食品药品管理局加长了对全身性重症肌无力研究性治疗的审查
MT Newswires ·  2023/01/27 04:16

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发